Phase III randomized trial of toremifene versus tamoxifen for Japanese postmenopausal patients with early breast cancer

[1] Kangas L(1998)Tamoxifen for early breast cancer: an overview of the randomized trials Lancet 351 1451-1467

[2] Kallio S(1986)A new triphenylethylene compound, Fc-1157a. II. Antitumor effect Cancer Chemother Pharmacol 17 109-113

[3] Blanco G(1995)Randomized comparison of tamoxifen and two separate doses of toremifene in postmenopausal patients with metastatic breast cancer J Clin Oncol 13 2556-2566

[4] Johansson R(1997)A phase III comparison of 2 toremifene doses to tamoxifen in postmenopausal women with advanced breast cancer. Eastern European Study Group Breast Cancer Res Treat 45 251-262

[5] Karjalainen A(1997)Comparison of toremifene and tamoxifen in post-menopausal patents with advanced breast cancer: a randomized double-blind, the ‘Nordic’ phase III study Br J Cancer 76 270-277

[6] Perilä M(1995)Tamoxifen and toremifene lower serum cholesterol by inhibition of Δ J Clin Oncol 13 2900-2905

[7] Hayes DF(1996)-cholesterol conversion to lathosterol in women with breast cancer J Clin Oncol 14 429-433

[8] Van Xyl JA(1998)Antiatherogenic effects of adjuvant antiestrogens: a randomized trial comparing the effects of tamoxifen and toremifene on plasma lipid levels in postmenopausal women with node-positive breast cancer J Clin Oncol 16 348-353

[9] Hacking A(1972)Tamoxifen and toremifene in breast cancer: comparison of safety and efficacy Clin Chem 18 499-502

[10] Goedhals L(1993)Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifugation Jpn Cancer Chemother. 20 247-258

[1] Kangas L(1998)Tamoxifen for early breast cancer: an overview of the randomized trials Lancet 351 1451-1467

[2] Kallio S(1986)A new triphenylethylene compound, Fc-1157a. II. Antitumor effect Cancer Chemother Pharmacol 17 109-113

[3] Blanco G(1995)Randomized comparison of tamoxifen and two separate doses of toremifene in postmenopausal patients with metastatic breast cancer J Clin Oncol 13 2556-2566

[4] Johansson R(1997)A phase III comparison of 2 toremifene doses to tamoxifen in postmenopausal women with advanced breast cancer. Eastern European Study Group Breast Cancer Res Treat 45 251-262

[5] Karjalainen A(1997)Comparison of toremifene and tamoxifen in post-menopausal patents with advanced breast cancer: a randomized double-blind, the ‘Nordic’ phase III study Br J Cancer 76 270-277

[6] Perilä M(1995)Tamoxifen and toremifene lower serum cholesterol by inhibition of Δ J Clin Oncol 13 2900-2905

[7] Hayes DF(1996)-cholesterol conversion to lathosterol in women with breast cancer J Clin Oncol 14 429-433

[8] Van Xyl JA(1998)Antiatherogenic effects of adjuvant antiestrogens: a randomized trial comparing the effects of tamoxifen and toremifene on plasma lipid levels in postmenopausal women with node-positive breast cancer J Clin Oncol 16 348-353

[9] Hacking A(1972)Tamoxifen and toremifene in breast cancer: comparison of safety and efficacy Clin Chem 18 499-502

[10] Goedhals L(1993)Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifugation Jpn Cancer Chemother. 20 247-258